It may be safe for women to extend intervals for cervical cancer screening to every 5 years or longer if screening results are consistently negative. New findings, published online November 27 in ...
Cotesting, the practice of adding cytology to human papillomavirus (HPV) screening, offered little added benefit over HPV testing alone in the detection of precancer among women aged 25-65 years, ...
UK-based independent technology and product development company, the Technology Partnership Plc (TTP), is seeking partnerships for CoTest, a new pooled screening technology for COVID-19. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results